Clinical Study
Indications and Outcomes of Uterine Artery Embolization in Patients with Uterine Leiomyomas
Table 3
Clinical outcomes of UAE in patients with uterine leiomyomas ().
| | Improvement of symptoms and/or reduction in the leiomyoma size | 24 | | Reduction in the leiomyoma volume at 6 months after UAE () | 67.9 ± 16.3% () | | Removal of submucosal leiomyoma | 8 | | Improvement of anemia | | | Hemoglobin value at 2 months after UAE (g/dL) | 8.5 ± 3.0 →11.5 ± 1.5 () | | Prognosis | | | No effect | 1 | | Hysterectomy | 3 | | Recurrence | 6 | | Complications | | | Abdominal pain, nausea, and fever | all the patients, short term | | Elevated liver enzymes | 1 | | Leg pain | 1 | | Menopause | none |
|
|
Mean ± standard deviation.
|
